3648 results for «491»

Filter By

3648 results

More on long-term responsiveness and effectiveness of renal denervation

21 May 2025 – From EuroPCR 2025

This session presents comprehensive data on the long-term responsiveness and effectiveness of renal denervation. Topics include outcomes in patients with chronic kidney disease, arterial stiffness correlations, safety profiles over nine years, and economic evaluations across European healthcare systems.

More on long-term responsiveness and effectiveness of renal denervation

DCB after REC-CAGEFREE 1 - Vulnerable plaque PCI after PREVENT

21 May 2025 – From EuroPCR 2025

Reflect on the impact of recent trials REC-CAGEFREE 1 and PREVENT on the use of drug-coated balloons (DCB) and preventive PCI for vulnerable plaque. This session includes case discussions highlighting DCB applications and insights from cutting-edge clinical studies.

DCB after REC-CAGEFREE 1 - Vulnerable plaque PCI after PREVENT

Calcified nodules: a different beast?

21 May 2025 – From EuroPCR 2025

This session offers a comprehensive exploration of calcified nodules, a challenging entity in PCI. Learn to identify these nodules with IVUS and OCT, understand their unique treatment challenges, and select optimal plaque modification tools through detailed case discussions.

Calcified nodules: a different beast?

ACS with normal coronary arteries: angiography done, job done?

21 May 2025 – From EuroPCR 2025

Understand the clinical significance of MINOCA and learn diagnostic strategies integrating invasive and non-invasive tests to identify underlying etiologies. This session provides therapeutic insights tailored to specific MINOCA endotypes through illustrative cases.

ACS with normal coronary arteries: angiography done, job done?

Treatment dilemmas in STEMI patients with multivessel disease

21 May 2025 – From EuroPCR 2025

Address treatment dilemmas in STEMI patients with multivessel disease through this session focused on imaging and physiology-guided revascularisation strategies. Learn optimal approaches for cases with CABG indications, and timing considerations for non-culprit vessel revascularisation during hospital admission or later stages, supported by illustrative clinical cases.

Treatment dilemmas in STEMI patients with multivessel disease

Management of high-risk left main lesion

21 May 2025 – From EuroPCR 2025

Focus on managing high-risk left main coronary lesions with this session featuring complex cases such as thrombotic lesions, calcified distal left main PCI with orbital atherectomy and IVUS guidance, and advanced stenting techniques. Learn practical approaches for challenging anatomical and clinical scenarios to optimize patient outcomes.

Management of high-risk left main lesion

Stent technologies, last evidence in coronary interventions

21 May 2025 – From EuroPCR 2025

Update your knowledge on the latest stent technologies and clinical evidence in coronary interventions. This session reviews long-term outcomes of resorbable magnesium scaffolds, seven-year data from the COMPARE-ABSORB trial, bioadaptor versus stent comparisons, dual therapy sirolimus-eluting versus biolimus-eluting stents, and randomized trials on direct stenting versus...

Stent technologies, last evidence in coronary interventions

Did danger shock change my practice?

21 May 2025 – From EuroPCR 2025

Reflect on how contemporary management of cardiogenic shock has evolved through this session. Review collaborative strategies, challenging clinical cases involving STEMI, multivessel disease, refractory shock, spontaneous coronary artery dissection, and the critical role of intracoronary imaging in guiding interventional decisions.

Did danger shock change my practice?

Case-based learning on different aspects of transcatheter LAA closure

21 May 2025 – From EuroPCR 2025

Engage in case-based learning focused on transcatheter left atrial appendage (LAA) closure. This session covers safe transseptal puncture techniques, state-of-the-art standard LAA closure procedures, management of challenging LAA anatomies, and optimization of post-procedure antithrombotic therapy in high-risk patients.

Case-based learning on different aspects of transcatheter LAA closure

Strategies in treating double CTO scenarios

21 May 2025 – From EuroPCR 2025

Navigate complex double chronic total occlusion (CTO) scenarios with this session that emphasizes thorough lesion qualification and innovative techniques. Learn strategies including management of ambiguous proximal caps, sequential vessel revascularization, and advanced tools like snaring and deflection to optimize procedural success.

Strategies in treating double CTO scenarios

Choices, choices: a global perspective on multiple modalities for calcium modification

21 May 2025 – From EuroPCR 2025

Gain a global perspective on multiple modalities for calcium modification in coronary interventions. This session reviews comparative analyses of orbital, shockwave, rotational atherectomy, and cutting balloons, explores evolving rotational atherectomy practices in the era of intravascular lithotripsy, and presents preliminary data from international registries on coronary...

Choices, choices: a global perspective on multiple modalities for calcium modification

TAVI for aortic regurgitation: off-label use

21 May 2025 – From EuroPCR 2025

Explore the complexities and off-label challenges of transcatheter aortic valve implantation (TAVI) in patients with severe pure aortic regurgitation. This session highlights the bold strategies, complication management, and innovative use of the Octacor valve in this demanding clinical scenario, providing valuable insights into navigating a difficult...

TAVI for aortic regurgitation: off-label use

Novel devices for edge-to-edge mitral repair

21 May 2025 – From EuroPCR 2025

Discover novel devices advancing transcatheter edge-to-edge mitral valve repair (TEER). This session presents clinical experiences with cost-effective and uniquely designed TEER systems for patients with degenerative mitral regurgitation and heart failure, including first-in-man applications and case series demonstrating safety and efficacy.

Novel devices for edge-to-edge mitral repair

DCB PCI: are we ready for complex de novo lesions?

21 May 2025 – From EuroPCR 2025

Evaluate the readiness of drug-coated balloon (DCB) therapy for complex de novo coronary lesions. This session reviews comparative outcomes of DCB versus drug-eluting stents (DES) across CHIP risk categories, impacts of diabetes, long-term follow-up data in calcified lesions and left main bifurcations, and treatment of in-stent...

DCB PCI: are we ready for complex de novo lesions?

Large thrombus burden: contemporary solutions

21 May 2025 – From EuroPCR 2025

This session presents contemporary strategies for managing large thrombus burden in STEMI patients. Learn from expert cases demonstrating multiple effective approaches including modified manual thrombus aspiration guided by intravascular ultrasound (IVUS) and streamlined primary PCI techniques, essential for optimizing outcomes in complex thrombotic scenarios.

Large thrombus burden: contemporary solutions

Overcoming resistant lesions in NSTEMI

21 May 2025 – From EuroPCR 2025

Address the challenges of resistant lesions in NSTEMI with this focused session. Learn from complex cases involving thrombus management using Penumbra systems and Guideliner, as well as strategies to overcome extensive calcification through multiple interventional tools, illustrating a stepwise approach to tackling difficult coronary lesions.

Overcoming resistant lesions in NSTEMI

Management of non-culprit lesions in patients with ACS and multivessel disease

21 May 2025 – From EuroPCR 2025

This session addresses the optimal management of non-culprit lesions (NCL) in patients with acute coronary syndrome (ACS) and multivessel disease. Learn about angiography, imaging, and FFR-guided strategies, timing considerations for PCI in high-risk NSTEMI patients, and patient selection for early staged PCI post-STEMI through detailed case...

Management of non-culprit lesions in patients with ACS and multivessel disease

High-risk plaque assessment with intracoronary imaging

21 May 2025 – From EuroPCR 2025

Explore high-risk plaque assessment using intracoronary imaging modalities such as OCT and AI-driven analysis. This session investigates associations between thin-cap fibroatheroma, local inflammation, and adverse outcomes, highlighting novel biomarkers and imaging techniques that enhance prognostic evaluation and guide personalized coronary artery disease management.

High-risk plaque assessment with intracoronary imaging

LAA closure and anthrombotic therapies

21 May 2025 – From EuroPCR 2025

Explore contemporary evidence on left atrial appendage (LAA) closure and associated antithrombotic therapies. This session covers strategies for antithrombotic de-escalation, efficacy and safety in patients with anticoagulation contraindications, breakthrough stroke etiology, and anatomical considerations in high-risk atrial fibrillation patients undergoing ablation.

LAA closure and anthrombotic therapies

The many faces of TTVR

21 May 2025 – From EuroPCR 2025

Discover the diverse clinical scenarios of transcatheter tricuspid valve replacement (TTVR). This session presents complex cases including acute right ventricular afterload mismatch, combined pulmonary and tricuspid valve interventions in carcinoid heart disease, and challenges in dilated cava anatomy, showcasing the expanding frontiers of TTVR therapy.

The many faces of TTVR
Didn’t find what you were looking for?